Psyllid ID: psy17031
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 419 | ||||||
| 403182979 | 326 | AAEL008652-PA, partial [Aedes aegypti] | 0.656 | 0.843 | 0.465 | 2e-73 | |
| 170039713 | 437 | cardioacceleratory peptide receptor [Cul | 0.565 | 0.542 | 0.534 | 3e-72 | |
| 328713510 | 405 | PREDICTED: cardioacceleratory peptide re | 0.544 | 0.562 | 0.521 | 4e-72 | |
| 195453795 | 502 | GK14383 [Drosophila willistoni] gi|19417 | 0.520 | 0.434 | 0.531 | 1e-71 | |
| 194743714 | 539 | GF18226 [Drosophila ananassae] gi|190627 | 0.486 | 0.378 | 0.549 | 1e-71 | |
| 270008192 | 336 | hypothetical protein TcasGA2_TC013945, p | 0.563 | 0.702 | 0.545 | 2e-71 | |
| 321470703 | 345 | hypothetical protein DAPPUDRAFT_317355 [ | 0.546 | 0.663 | 0.530 | 3e-71 | |
| 195389602 | 501 | GJ23325 [Drosophila virilis] gi|19415155 | 0.486 | 0.407 | 0.545 | 3e-71 | |
| 195349581 | 506 | GM10207 [Drosophila sechellia] gi|194123 | 0.565 | 0.468 | 0.501 | 4e-71 | |
| 90110012 | 506 | RecName: Full=Cardioacceleratory peptide | 0.565 | 0.468 | 0.501 | 4e-71 |
| >gi|403182979|gb|EAT39546.2| AAEL008652-PA, partial [Aedes aegypti] | Back alignment and taxonomy information |
|---|
Score = 282 bits (721), Expect = 2e-73, Method: Compositional matrix adjust.
Identities = 169/363 (46%), Positives = 208/363 (57%), Gaps = 88/363 (24%)
Query: 95 TEQFVILWALFILIVLGNSAVIFTLKFGVKRRSRMNFFIMHLAVADLCVGVLSVLTDIVW 154
TEQF +LW LFI+IVLGN AV+ TL R+SRMNFFI LA+ADL VG+LSVLTDIV
Sbjct: 1 TEQFAVLWILFIVIVLGNLAVLVTLFMNKNRKSRMNFFIKQLAIADLSVGLLSVLTDIVQ 60
Query: 155 RSSVTWKAGNTACKVVRYSQAVVTYSSTYVLVALSIDRYYAIKYPMNFCGSCKYIRDLCV 214
R +++W AGN ACKV+R+ Q VTY+STYVLVALSIDRY AI +PMNF G CK+ V
Sbjct: 61 RITISWLAGNVACKVIRFIQVWVTYASTYVLVALSIDRYDAITHPMNFSGCCKFDAMPMV 120
Query: 215 GVLSVLTDIVWRSSVTWKAGNTACKVVRYSQAVVTYSSTYVLVALSIDRYYAIKYPMNFC 274
+ VL++ +SI+ +
Sbjct: 121 LLRPVLSE-----------------------------------KISIESVF--------- 136
Query: 275 GSWRRARWLVGIAWLISFILSIPIAVLFHVRLVQGTSQCWIEFEKPWQWQLYMSLVALAL 334
+ +RAR LVG AW S I S P+ L+ R++Q QCWI+ +WQLYM VA +L
Sbjct: 137 -NRKRARRLVGAAWGFSAIFSSPMFYLYEERVIQDQLQCWIDLGNALRWQLYMCWVATSL 195
Query: 335 FVIPAVIISICYILIITTIWA---------------------------------KSKLYT 361
FVIPA IIS CY++II TIW+ K+K+ T
Sbjct: 196 FVIPAFIISACYVIIIKTIWSKGSVLGPVGGKYRYRNGSAELARRRASSRGIIPKAKVKT 255
Query: 362 ----------FVLCWSPYIVFDLLQVYGYIPRTQNYIAVATLIQSLAPLNSAANPIIYCI 411
FVLCWSPYIVFDLLQV+ IP+TQ IA+AT IQSLAPLNSAANP+IYC+
Sbjct: 256 VKMTIVIVIVFVLCWSPYIVFDLLQVFEQIPKTQTNIAIATFIQSLAPLNSAANPLIYCL 315
Query: 412 FRT 414
F T
Sbjct: 316 FST 318
|
Source: Aedes aegypti Species: Aedes aegypti Genus: Aedes Family: Culicidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|170039713|ref|XP_001847670.1| cardioacceleratory peptide receptor [Culex quinquefasciatus] gi|167863294|gb|EDS26677.1| cardioacceleratory peptide receptor [Culex quinquefasciatus] | Back alignment and taxonomy information |
|---|
| >gi|328713510|ref|XP_003245097.1| PREDICTED: cardioacceleratory peptide receptor-like [Acyrthosiphon pisum] | Back alignment and taxonomy information |
|---|
| >gi|195453795|ref|XP_002073946.1| GK14383 [Drosophila willistoni] gi|194170031|gb|EDW84932.1| GK14383 [Drosophila willistoni] | Back alignment and taxonomy information |
|---|
| >gi|194743714|ref|XP_001954345.1| GF18226 [Drosophila ananassae] gi|190627382|gb|EDV42906.1| GF18226 [Drosophila ananassae] | Back alignment and taxonomy information |
|---|
| >gi|270008192|gb|EFA04640.1| hypothetical protein TcasGA2_TC013945, partial [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
| >gi|321470703|gb|EFX81678.1| hypothetical protein DAPPUDRAFT_317355 [Daphnia pulex] | Back alignment and taxonomy information |
|---|
| >gi|195389602|ref|XP_002053465.1| GJ23325 [Drosophila virilis] gi|194151551|gb|EDW66985.1| GJ23325 [Drosophila virilis] | Back alignment and taxonomy information |
|---|
| >gi|195349581|ref|XP_002041321.1| GM10207 [Drosophila sechellia] gi|194123016|gb|EDW45059.1| GM10207 [Drosophila sechellia] | Back alignment and taxonomy information |
|---|
| >gi|90110012|sp|Q868T3.3|CCAPR_DROME RecName: Full=Cardioacceleratory peptide receptor gi|60729595|pir||JC7952 crustacean cardioactive peptide receptor (CG6111) - fruit fly (Drosophila melanogaster) gi|29169183|gb|AAO66429.1| CCAP receptor [Drosophila melanogaster] | Back alignment and taxonomy information |
|---|
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 419 | ||||||
| FB|FBgn0039396 | 506 | CcapR "Cardioacceleratory pept | 0.436 | 0.361 | 0.502 | 1.6e-67 | |
| RGD|1564154 | 372 | Npsr1 "neuropeptide S receptor | 0.400 | 0.451 | 0.405 | 7.9e-55 | |
| MGI|MGI:2441738 | 371 | Npsr1 "neuropeptide S receptor | 0.400 | 0.452 | 0.408 | 1e-54 | |
| UNIPROTKB|F1MJZ0 | 370 | NPSR1 "Uncharacterized protein | 0.400 | 0.454 | 0.408 | 2.6e-54 | |
| UNIPROTKB|Q6W5P4 | 371 | NPSR1 "Neuropeptide S receptor | 0.400 | 0.452 | 0.414 | 4.2e-54 | |
| UNIPROTKB|E1BUZ1 | 373 | NPSR1 "Uncharacterized protein | 0.508 | 0.571 | 0.357 | 3.7e-44 | |
| UNIPROTKB|F1Q0I5 | 302 | NPSR1 "Uncharacterized protein | 0.381 | 0.529 | 0.413 | 9.6e-44 | |
| UNIPROTKB|F1SIK6 | 297 | NPSR1 "Uncharacterized protein | 0.372 | 0.525 | 0.414 | 1.2e-43 | |
| UNIPROTKB|F1NV74 | 370 | AVPR2 "Uncharacterized protein | 0.310 | 0.351 | 0.320 | 1e-25 | |
| UNIPROTKB|Q5WA50 | 426 | CTR2 "Cephalotocin receptor 2" | 0.350 | 0.345 | 0.313 | 3e-25 |
| FB|FBgn0039396 CcapR "Cardioacceleratory peptide receptor" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 479 (173.7 bits), Expect = 1.6e-67, Sum P(2) = 1.6e-67
Identities = 93/185 (50%), Positives = 123/185 (66%)
Query: 176 VVTYSSTYVLVALSIDRYYAIKYPMNFCGSCKYIRDLCVGVLSVLTDIVWRSSVTWKAGN 235
V+ ++ VL + I++ K MN+ + DLCVG+L+VLTDI+WR +++W+AGN
Sbjct: 136 VIVLGNSAVLFVMFINKNR--KSRMNYFIKQLALADLCVGLLNVLTDIIWRITISWRAGN 193
Query: 236 TACKVVRYSQAVVTYSSTYVLVALSIDRYYAIKYPMNFCGSWRRARWLVGIAWLISFILS 295
ACK +R+SQ VTYSSTYVLVA+SIDRY AI +PMNF SW+RAR LV AWLIS + S
Sbjct: 194 LACKAIRFSQVCVTYSSTYVLVAMSIDRYDAITHPMNFSKSWKRARHLVAGAWLISALFS 253
Query: 296 IPIAVLFHVRLVQGTSQCWIEFEKPWQWQLYMSLVALALFVIPAVXXXXXXXXXXXXXWA 355
+PI VL+ +L+QG QCWIE P WQ+YMSLV+ LF IPA+ WA
Sbjct: 254 LPILVLYEEKLIQGHPQCWIELGSPIAWQVYMSLVSATLFAIPALIISACYAIIVKTIWA 313
Query: 356 KSKLY 360
K ++
Sbjct: 314 KGSIF 318
|
|
| RGD|1564154 Npsr1 "neuropeptide S receptor 1" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
| MGI|MGI:2441738 Npsr1 "neuropeptide S receptor 1" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|F1MJZ0 NPSR1 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|Q6W5P4 NPSR1 "Neuropeptide S receptor" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|E1BUZ1 NPSR1 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|F1Q0I5 NPSR1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|F1SIK6 NPSR1 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|F1NV74 AVPR2 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|Q5WA50 CTR2 "Cephalotocin receptor 2" [Octopus vulgaris (taxid:6645)] | Back alignment and assigned GO terms |
|---|
Prediction of Enzyme Commission (EC) Number
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 419 | |||
| pfam00001 | 251 | pfam00001, 7tm_1, 7 transmembrane receptor (rhodop | 6e-26 | |
| PHA03087 | 335 | PHA03087, PHA03087, G protein-coupled chemokine re | 4e-12 | |
| pfam00001 | 251 | pfam00001, 7tm_1, 7 transmembrane receptor (rhodop | 1e-11 | |
| PHA02638 | 417 | PHA02638, PHA02638, CC chemokine receptor-like pro | 2e-07 | |
| PHA03087 | 335 | PHA03087, PHA03087, G protein-coupled chemokine re | 8e-06 | |
| PHA02638 | 417 | PHA02638, PHA02638, CC chemokine receptor-like pro | 2e-05 | |
| PHA02834 | 323 | PHA02834, PHA02834, chemokine receptor-like protei | 8e-04 |
| >gnl|CDD|215646 pfam00001, 7tm_1, 7 transmembrane receptor (rhodopsin family) | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 6e-26
Identities = 63/228 (27%), Positives = 104/228 (45%), Gaps = 29/228 (12%)
Query: 211 DLCVGVLSVLTDIVWRSSVTWKAGNTACKVVRYSQAVVTYSSTYVLVALSIDRYYAIKYP 270
DL + + + W G+ CK+V + V Y+S +L A+SIDRY AI +P
Sbjct: 24 DLLFLLTLPPWALYYLVGGDWPFGDALCKLVGFLFVVNGYASILLLTAISIDRYLAIVHP 83
Query: 271 M--NFCGSWRRARWLVGIAWLISFILSIPIAVLFHVRLVQGTSQ--CWIEFEKPWQWQLY 326
+ + RRA+ L+ + W+++ +LS+P + +R V+ + C I+F + + Y
Sbjct: 84 LRYRRIRTPRRAKVLILVVWVLALLLSLPPLLFSWLRTVEEGNVTTCLIDFPEESTKRSY 143
Query: 327 MSLVALALFVIPAVIISICYILIITTIWAKSKLY-------------------------T 361
L L FV+P ++I +CY LI+ T+ +++
Sbjct: 144 TLLSTLLGFVLPLLVILVCYTLILRTLRKRARSGASQARAKRSSSKERKAAKMLLVVVVV 203
Query: 362 FVLCWSPYIVFDLLQVYGYIPRTQNYIAVATLIQSLAPLNSAANPIIY 409
FVLCW PY + LL + + + LA +NS NPIIY
Sbjct: 204 FVLCWLPYHIVLLLDSLCPLSIWRLLPTALLITLWLAYVNSCLNPIIY 251
|
This family contains, amongst other G-protein-coupled receptors (GCPRs), members of the opsin family, which have been considered to be typical members of the rhodopsin superfamily. They share several motifs, mainly the seven transmembrane helices, GCPRs of the rhodopsin superfamily. All opsins bind a chromophore, such as 11-cis-retinal. The function of most opsins other than the photoisomerases is split into two steps: light absorption and G-protein activation. Photoisomerases, on the other hand, are not coupled to G-proteins - they are thought to generate and supply the chromophore that is used by visual opsins. Length = 251 |
| >gnl|CDD|222976 PHA03087, PHA03087, G protein-coupled chemokine receptor-like protein; Provisional | Back alignment and domain information |
|---|
| >gnl|CDD|215646 pfam00001, 7tm_1, 7 transmembrane receptor (rhodopsin family) | Back alignment and domain information |
|---|
| >gnl|CDD|165021 PHA02638, PHA02638, CC chemokine receptor-like protein; Provisional | Back alignment and domain information |
|---|
| >gnl|CDD|222976 PHA03087, PHA03087, G protein-coupled chemokine receptor-like protein; Provisional | Back alignment and domain information |
|---|
| >gnl|CDD|165021 PHA02638, PHA02638, CC chemokine receptor-like protein; Provisional | Back alignment and domain information |
|---|
| >gnl|CDD|165177 PHA02834, PHA02834, chemokine receptor-like protein; Provisional | Back alignment and domain information |
|---|
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 419 | |||
| KOG4219|consensus | 423 | 100.0 | ||
| PHA03234 | 338 | DNA packaging protein UL33; Provisional | 100.0 | |
| PHA02834 | 323 | chemokine receptor-like protein; Provisional | 100.0 | |
| PHA03235 | 409 | DNA packaging protein UL33; Provisional | 100.0 | |
| KOG4220|consensus | 503 | 99.97 | ||
| PHA02638 | 417 | CC chemokine receptor-like protein; Provisional | 99.97 | |
| PHA03087 | 335 | G protein-coupled chemokine receptor-like protein; | 99.97 | |
| PF00001 | 257 | 7tm_1: 7 transmembrane receptor (rhodopsin family) | 99.94 | |
| KOG2087|consensus | 363 | 99.86 | ||
| PF10320 | 257 | 7TM_GPCR_Srsx: Serpentine type 7TM GPCR chemorecep | 99.66 | |
| PHA03234 | 338 | DNA packaging protein UL33; Provisional | 99.63 | |
| PHA03235 | 409 | DNA packaging protein UL33; Provisional | 99.45 | |
| PF10324 | 318 | 7TM_GPCR_Srw: Serpentine type 7TM GPCR chemorecept | 99.42 | |
| PHA02638 | 417 | CC chemokine receptor-like protein; Provisional | 99.4 | |
| PHA02834 | 323 | chemokine receptor-like protein; Provisional | 99.39 | |
| PHA03087 | 335 | G protein-coupled chemokine receptor-like protein; | 99.32 | |
| PF10328 | 274 | 7TM_GPCR_Srx: Serpentine type 7TM GPCR chemorecept | 99.01 | |
| KOG2087|consensus | 363 | 98.92 | ||
| PF00001 | 257 | 7tm_1: 7 transmembrane receptor (rhodopsin family) | 98.88 | |
| PF05296 | 303 | TAS2R: Mammalian taste receptor protein (TAS2R); I | 98.81 | |
| PF05462 | 303 | Dicty_CAR: Slime mold cyclic AMP receptor | 98.8 | |
| PF10323 | 283 | 7TM_GPCR_Srv: Serpentine type 7TM GPCR chemorecept | 98.77 | |
| KOG4219|consensus | 423 | 98.23 | ||
| PF11710 | 201 | Git3: G protein-coupled glucose receptor regulatin | 98.2 | |
| PF10320 | 257 | 7TM_GPCR_Srsx: Serpentine type 7TM GPCR chemorecep | 98.09 | |
| PF10321 | 313 | 7TM_GPCR_Srt: Serpentine type 7TM GPCR chemorecept | 98.01 | |
| PF10317 | 292 | 7TM_GPCR_Srd: Serpentine type 7TM GPCR chemorecept | 97.84 | |
| KOG4220|consensus | 503 | 97.72 | ||
| PF03402 | 265 | V1R: Vomeronasal organ pheromone receptor family, | 97.71 | |
| PF10292 | 324 | 7TM_GPCR_Srab: Serpentine type 7TM GPCR receptor c | 97.57 | |
| PF10327 | 303 | 7TM_GPCR_Sri: Serpentine type 7TM GPCR chemorecept | 97.46 | |
| PF10326 | 307 | 7TM_GPCR_Str: Serpentine type 7TM GPCR chemorecept | 97.36 | |
| PF02118 | 275 | Srg: Srg family chemoreceptor; InterPro: IPR000609 | 96.96 | |
| PF10328 | 274 | 7TM_GPCR_Srx: Serpentine type 7TM GPCR chemorecept | 96.86 | |
| PF10319 | 310 | 7TM_GPCR_Srj: Serpentine type 7TM GPCR chemorecept | 96.46 | |
| PF02101 | 405 | Ocular_alb: Ocular albinism type 1 protein; InterP | 96.38 | |
| PF04789 | 305 | DUF621: Protein of unknown function (DUF621); Inte | 95.96 | |
| PF00002 | 242 | 7tm_2: 7 transmembrane receptor (Secretin family); | 95.69 | |
| PF02117 | 328 | 7TM_GPCR_Sra: Serpentine type 7TM GPCR chemorecept | 95.13 | |
| PF10316 | 273 | 7TM_GPCR_Srbc: Serpentine type 7TM GPCR chemorecep | 93.94 | |
| PF10322 | 307 | 7TM_GPCR_Sru: Serpentine type 7TM GPCR chemorecept | 91.86 | |
| PF10318 | 302 | 7TM_GPCR_Srh: Serpentine type 7TM GPCR chemorecept | 90.85 | |
| PF10324 | 318 | 7TM_GPCR_Srw: Serpentine type 7TM GPCR chemorecept | 89.54 | |
| KOG4193|consensus | 610 | 87.69 | ||
| PF01534 | 328 | Frizzled: Frizzled/Smoothened family membrane regi | 87.4 | |
| PF10323 | 283 | 7TM_GPCR_Srv: Serpentine type 7TM GPCR chemorecept | 85.04 | |
| PF02175 | 236 | 7TM_GPCR_Srb: Serpentine type 7TM GPCR chemorecept | 83.64 | |
| PF06681 | 226 | DUF1182: Protein of unknown function (DUF1182); In | 81.54 |
| >KOG4219|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=298.31 Aligned_cols=261 Identities=23% Similarity=0.441 Sum_probs=215.6
Q ss_pred cccccccchHHHHHHHHHHHHHHhhhheeeEEeEecccccchhhHHHHHHHHHHHHHHHHhhHHHHHHhhcccccccccc
Q psy17031 87 IRTLTKLNTEQFVILWALFILIVLGNSAVIFTLKFGVKRRSRMNFFIMHLAVADLCVGVLSVLTDIVWRSSVTWKAGNTA 166 (419)
Q Consensus 87 ~~~~~~~~~~~~~~~~~i~~vgl~gN~lvl~~i~~~~~~~~~~~~~i~~La~aDll~~~~~~p~~~~~~~~~~~~~~~~~ 166 (419)
...+........+++..+.+++++||+++++++..+|++|+.+|+|+.|||+||+.++++..++.........|.+|+.+
T Consensus 28 f~lp~~~~~~wai~yg~l~~vAv~GN~iVlwIil~hrrMRtvtnyfL~NLAfADl~~s~Fn~~f~f~yal~~~W~~G~f~ 107 (423)
T KOG4219|consen 28 FVLPAWQQALWAIAYGLLVFVAVVGNLIVLWIILAHRRMRTVTNYFLVNLAFADLSMSIFNTVFNFQYALHQEWYFGSFY 107 (423)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHhcCceEEEEEeehhehhhhHHHHHHHHHHHHHHHHHHhhHHHHHHHHHhccccccce
Confidence 34444455566788889999999999999999999999999999999999999999999999999999888999999999
Q ss_pred eeeeeeeceeehhhhhhHHHHHhhhhhhhhccCcccccccchhcccccceeeeeeeeeeecceeccccccccchhhhHHH
Q psy17031 167 CKVVRYSQAVVTYSSTYVLVALSIDRYYAIKYPMNFCGSCKYIRDLCVGVLSVLTDIVWRSSVTWKAGNTACKVVRYSQA 246 (419)
Q Consensus 167 C~~~~~~~~~~~~~s~~~L~~is~dRy~aI~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~~~~~C~~~~~~~~ 246 (419)
|+++.|+......+|+++|+|||+|||+||.||+
T Consensus 108 C~f~nf~~itav~vSVfTlvAiA~DRy~AIi~Pl---------------------------------------------- 141 (423)
T KOG4219|consen 108 CRFVNFFPITAVFVSVFTLVAIAIDRYMAIIHPL---------------------------------------------- 141 (423)
T ss_pred eeeccccchhhhhHhHHHHHHHHHHHHHHHhhhc----------------------------------------------
Confidence 9999998888888888888888877777777664
Q ss_pred HHHHHHHHHHHHHHHhhheeeeccccccccchhhhHHHHHHHHHHHHHHHHHHHhheeEeecC-----CCceeeccccc-
Q psy17031 247 VVTYSSTYVLVALSIDRYYAIKYPMNFCGSWRRARWLVGIAWLISFILSIPIAVLFHVRLVQG-----TSQCWIEFEKP- 320 (419)
Q Consensus 247 ~~~~~s~~~l~~i~~~Ry~~i~~p~~~~~t~~~~~~~i~~~W~~s~~~~~p~~~~~~~~~~~~-----~~~C~~~~~~~- 320 (419)
+.+.++|...+.+.++|+++++++.|..........+. ...|...++++
T Consensus 142 -------------------------~~r~s~r~sk~iIllIW~lA~l~a~P~~l~s~v~~~~~~d~~~~~~~~~~~pe~~ 196 (423)
T KOG4219|consen 142 -------------------------QPRPSRRSSKIIILLIWALALLLALPQLLYSSVEELYLYDGESRVVCVTAWPEHV 196 (423)
T ss_pred -------------------------ccCCCCcceeehhHHHHHHHHHHhccceeeeeeEEeeccCCcceEEEEEeccccc
Confidence 44557888889999999999999999999877665543 45565555443
Q ss_pred ----hhH---HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCc-------------------------eEEEEEechh
Q psy17031 321 ----WQW---QLYMSLVALALFVIPAVIISICYILIITTIWAKSK-------------------------LYTFVLCWSP 368 (419)
Q Consensus 321 ----~~~---~~~~~~~~~~~~~vp~~ii~~~y~~i~~~l~~~~~-------------------------~~~f~~cw~P 368 (419)
... +.|.....++.+++|++++...|..|.+++|+++. ++.|.+||+|
T Consensus 197 ~~~~~~~~~~~~y~~vl~~lqYflPliVl~~~Yt~iav~LW~~~~~gd~~d~~~~~~kak~K~vkmliiVV~~FaicWlP 276 (423)
T KOG4219|consen 197 CPTENESLLMQGYNYVLLFLQYFLPLIVLGLAYTVIAVTLWGRRIPGDQQDRKHEQLKAKKKVVKMLIIVVVIFAICWLP 276 (423)
T ss_pred CCcchhhhhhcceeeeehhHHHHHHHHHHHHHHHHHHHHHHhccCccchhchhhHHHHHHHHHHHHHHHHHHHHHHhccC
Confidence 111 22667778899999999999999999999998654 7999999999
Q ss_pred HHHHHHHHHhcC-cCCCchhhHHHHHHHHHhccccccchhhhhcccCCccC
Q psy17031 369 YIVFDLLQVYGY-IPRTQNYIAVATLIQSLAPLNSAANPIIYCIFRTGNNN 418 (419)
Q Consensus 369 ~~v~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~s~~nP~iY~~~~~~fR~ 418 (419)
++.+.++..... ..+.......+....||++.|+|+||+||++.|++||.
T Consensus 277 yh~y~il~~~~~~i~~~k~i~~vyl~~~WLaMSst~yNPiIY~~lN~Rfr~ 327 (423)
T KOG4219|consen 277 YHIYFILNATNPEINRKKFIQQVYLAIYWLAMSSTCYNPIIYCFLNKRFRG 327 (423)
T ss_pred hhHHHHHHHhHHHHHHHHHHHHHHHHHHHHHHHHhhhccHhhhhhHHHHHH
Confidence 999999875543 22333334466678999999999999999999999884
|
|
| >PHA03234 DNA packaging protein UL33; Provisional | Back alignment and domain information |
|---|
| >PHA02834 chemokine receptor-like protein; Provisional | Back alignment and domain information |
|---|
| >PHA03235 DNA packaging protein UL33; Provisional | Back alignment and domain information |
|---|
| >KOG4220|consensus | Back alignment and domain information |
|---|
| >PHA02638 CC chemokine receptor-like protein; Provisional | Back alignment and domain information |
|---|
| >PHA03087 G protein-coupled chemokine receptor-like protein; Provisional | Back alignment and domain information |
|---|
| >PF00001 7tm_1: 7 transmembrane receptor (rhodopsin family) Rhodopsin-like GPCR superfamily signature 5-hydroxytryptamine 7 receptor signature bradykinin receptor signature gastrin receptor signature melatonin receptor signature olfactory receptor signature; InterPro: IPR000276 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >KOG2087|consensus | Back alignment and domain information |
|---|
| >PF10320 7TM_GPCR_Srsx: Serpentine type 7TM GPCR chemoreceptor Srsx; InterPro: IPR019424 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PHA03234 DNA packaging protein UL33; Provisional | Back alignment and domain information |
|---|
| >PHA03235 DNA packaging protein UL33; Provisional | Back alignment and domain information |
|---|
| >PF10324 7TM_GPCR_Srw: Serpentine type 7TM GPCR chemoreceptor Srw; InterPro: IPR019427 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PHA02638 CC chemokine receptor-like protein; Provisional | Back alignment and domain information |
|---|
| >PHA02834 chemokine receptor-like protein; Provisional | Back alignment and domain information |
|---|
| >PHA03087 G protein-coupled chemokine receptor-like protein; Provisional | Back alignment and domain information |
|---|
| >PF10328 7TM_GPCR_Srx: Serpentine type 7TM GPCR chemoreceptor Srx; InterPro: IPR019430 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >KOG2087|consensus | Back alignment and domain information |
|---|
| >PF00001 7tm_1: 7 transmembrane receptor (rhodopsin family) Rhodopsin-like GPCR superfamily signature 5-hydroxytryptamine 7 receptor signature bradykinin receptor signature gastrin receptor signature melatonin receptor signature olfactory receptor signature; InterPro: IPR000276 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF05296 TAS2R: Mammalian taste receptor protein (TAS2R); InterPro: IPR007960 This family consists of several forms of mammalian taste receptor proteins (TAS2Rs) | Back alignment and domain information |
|---|
| >PF05462 Dicty_CAR: Slime mold cyclic AMP receptor | Back alignment and domain information |
|---|
| >PF10323 7TM_GPCR_Srv: Serpentine type 7TM GPCR chemoreceptor Srv; InterPro: IPR019426 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >KOG4219|consensus | Back alignment and domain information |
|---|
| >PF11710 Git3: G protein-coupled glucose receptor regulating Gpa2; InterPro: IPR023041 This entry contains a functionally uncharacterised region belonging to the Git3 G-protein coupled receptor | Back alignment and domain information |
|---|
| >PF10320 7TM_GPCR_Srsx: Serpentine type 7TM GPCR chemoreceptor Srsx; InterPro: IPR019424 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF10321 7TM_GPCR_Srt: Serpentine type 7TM GPCR chemoreceptor Srt; InterPro: IPR019425 Chemoreception is mediated in Caenorhabditis elegans by members of the seven-transmembrane G-protein-coupled receptor class (7TM GPCRs) of proteins which are of the serpentine type [] | Back alignment and domain information |
|---|
| >PF10317 7TM_GPCR_Srd: Serpentine type 7TM GPCR chemoreceptor Srd; InterPro: IPR019421 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >KOG4220|consensus | Back alignment and domain information |
|---|
| >PF03402 V1R: Vomeronasal organ pheromone receptor family, V1R; InterPro: IPR004072 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF10292 7TM_GPCR_Srab: Serpentine type 7TM GPCR receptor class ab chemoreceptor; InterPro: IPR019408 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF10327 7TM_GPCR_Sri: Serpentine type 7TM GPCR chemoreceptor Sri; InterPro: IPR019429 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF10326 7TM_GPCR_Str: Serpentine type 7TM GPCR chemoreceptor Str; InterPro: IPR019428 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF02118 Srg: Srg family chemoreceptor; InterPro: IPR000609 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF10328 7TM_GPCR_Srx: Serpentine type 7TM GPCR chemoreceptor Srx; InterPro: IPR019430 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF10319 7TM_GPCR_Srj: Serpentine type 7TM GPCR chemoreceptor Srj; InterPro: IPR019423 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF02101 Ocular_alb: Ocular albinism type 1 protein; InterPro: IPR001414 Ocular albinism type 1 (OA1) is an X-linked disorder characterised by severe impairment of visual acuity, retinal hypopigmentation and the presence of macromelanosomes | Back alignment and domain information |
|---|
| >PF04789 DUF621: Protein of unknown function (DUF621); InterPro: IPR006874 This is a conserved region found in uncharacterised proteins from Caenorhabditis elegans, and is noted to have possible G-protein-coupled receptor-like activity | Back alignment and domain information |
|---|
| >PF00002 7tm_2: 7 transmembrane receptor (Secretin family); InterPro: IPR000832 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF02117 7TM_GPCR_Sra: Serpentine type 7TM GPCR chemoreceptor Sra; InterPro: IPR000344 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF10316 7TM_GPCR_Srbc: Serpentine type 7TM GPCR chemoreceptor Srbc ; InterPro: IPR019420 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF10322 7TM_GPCR_Sru: Serpentine type 7TM GPCR chemoreceptor Sru; InterPro: IPR003839 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF10318 7TM_GPCR_Srh: Serpentine type 7TM GPCR chemoreceptor Srh; InterPro: IPR019422 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF10324 7TM_GPCR_Srw: Serpentine type 7TM GPCR chemoreceptor Srw; InterPro: IPR019427 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >KOG4193|consensus | Back alignment and domain information |
|---|
| >PF01534 Frizzled: Frizzled/Smoothened family membrane region; InterPro: IPR000539 The frizzled (fz) locus of Drosophila coordinates the cytoskeletons of epidermal cells, producing a parallel array of cuticular hairs and bristles [, ] | Back alignment and domain information |
|---|
| >PF10323 7TM_GPCR_Srv: Serpentine type 7TM GPCR chemoreceptor Srv; InterPro: IPR019426 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF02175 7TM_GPCR_Srb: Serpentine type 7TM GPCR chemoreceptor Srb; InterPro: IPR002184 G-protein-coupled receptors, GPCRs, constitute a vast protein family that encompasses a wide range of functions (including various autocrine, paracrine and endocrine processes) | Back alignment and domain information |
|---|
| >PF06681 DUF1182: Protein of unknown function (DUF1182); InterPro: IPR010601 This family consists of several hypothetical proteins of around 360 residues in length and seems to be specific to Caenorhabditis elegans | Back alignment and domain information |
|---|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 419 | ||||
| 4ea3_B | 434 | Structure Of The NOFQ OPIOID RECEPTOR IN COMPLEX WI | 3e-09 | ||
| 3oe0_A | 499 | Crystal Structure Of The Cxcr4 Chemokine Receptor I | 3e-07 | ||
| 3odu_A | 502 | The 2.5 A Structure Of The Cxcr4 Chemokine Receptor | 3e-07 | ||
| 3oe6_A | 508 | Crystal Structure Of The Cxcr4 Chemokine Receptor I | 3e-07 | ||
| 3eml_A | 488 | The 2.6 A Crystal Structure Of A Human A2a Adenosin | 3e-07 | ||
| 3eml_A | 488 | The 2.6 A Crystal Structure Of A Human A2a Adenosin | 4e-05 | ||
| 4daj_A | 479 | Structure Of The M3 Muscarinic Acetylcholine Recept | 6e-07 | ||
| 4daj_A | 479 | Structure Of The M3 Muscarinic Acetylcholine Recept | 1e-06 | ||
| 3vg9_A | 326 | Crystal Structure Of Human Adenosine A2a Receptor W | 7e-07 | ||
| 3vg9_A | 326 | Crystal Structure Of Human Adenosine A2a Receptor W | 2e-05 | ||
| 4dkl_A | 464 | Crystal Structure Of The Mu-Opioid Receptor Bound T | 8e-07 | ||
| 4eiy_A | 447 | Crystal Structure Of The Chimeric Protein Of A2aar- | 1e-06 | ||
| 4eiy_A | 447 | Crystal Structure Of The Chimeric Protein Of A2aar- | 4e-05 | ||
| 2ydo_A | 325 | Thermostabilised Human A2a Receptor With Adenosine | 5e-06 | ||
| 2ydo_A | 325 | Thermostabilised Human A2a Receptor With Adenosine | 3e-05 | ||
| 3pwh_A | 329 | Thermostabilised Adenosine A2a Receptor Length = 32 | 6e-06 | ||
| 3pwh_A | 329 | Thermostabilised Adenosine A2a Receptor Length = 32 | 6e-04 | ||
| 4djh_A | 480 | Structure Of The Human Kappa Opioid Receptor In Com | 1e-05 | ||
| 4djh_A | 480 | Structure Of The Human Kappa Opioid Receptor In Com | 2e-04 | ||
| 4gbr_A | 309 | N-terminal T4 Lysozyme Fusion Facilitates Crystalli | 2e-05 | ||
| 3uon_A | 467 | Structure Of The Human M2 Muscarinic Acetylcholine | 2e-05 | ||
| 3uon_A | 467 | Structure Of The Human M2 Muscarinic Acetylcholine | 2e-04 | ||
| 4ej4_A | 461 | Structure Of The Delta Opioid Receptor Bound To Nal | 4e-05 | ||
| 2vt4_A | 313 | Turkey Beta1 Adrenergic Receptor With Stabilising M | 7e-05 | ||
| 2y00_B | 315 | Turkey Beta1 Adrenergic Receptor With Stabilising M | 7e-05 | ||
| 2ks9_A | 364 | Solution Conformation Of Substance P In Water Compl | 2e-04 | ||
| 3vw7_A | 484 | Crystal Structure Of Human Protease-Activated Recep | 3e-04 | ||
| 3sn6_R | 514 | Crystal Structure Of The Beta2 Adrenergic Receptor- | 7e-04 |
| >pdb|4EA3|B Chain B, Structure Of The NOFQ OPIOID RECEPTOR IN COMPLEX WITH A PEPTIDE Mimetic Length = 434 | Back alignment and structure |
|
| >pdb|3OE0|A Chain A, Crystal Structure Of The Cxcr4 Chemokine Receptor In Complex With A Cyclic Peptide Antagonist Cvx15 Length = 499 | Back alignment and structure |
| >pdb|3ODU|A Chain A, The 2.5 A Structure Of The Cxcr4 Chemokine Receptor In Complex With Small Molecule Antagonist It1t Length = 502 | Back alignment and structure |
| >pdb|3OE6|A Chain A, Crystal Structure Of The Cxcr4 Chemokine Receptor In Complex With A Small Molecule Antagonist It1t In I222 Spacegroup Length = 508 | Back alignment and structure |
| >pdb|3EML|A Chain A, The 2.6 A Crystal Structure Of A Human A2a Adenosine Receptor Bound To Zm241385. Length = 488 | Back alignment and structure |
| >pdb|3EML|A Chain A, The 2.6 A Crystal Structure Of A Human A2a Adenosine Receptor Bound To Zm241385. Length = 488 | Back alignment and structure |
| >pdb|4DAJ|A Chain A, Structure Of The M3 Muscarinic Acetylcholine Receptor Length = 479 | Back alignment and structure |
| >pdb|4DAJ|A Chain A, Structure Of The M3 Muscarinic Acetylcholine Receptor Length = 479 | Back alignment and structure |
| >pdb|3VG9|A Chain A, Crystal Structure Of Human Adenosine A2a Receptor With An Allosteric Inverse-Agonist Antibody At 2.7 A Resolution Length = 326 | Back alignment and structure |
| >pdb|3VG9|A Chain A, Crystal Structure Of Human Adenosine A2a Receptor With An Allosteric Inverse-Agonist Antibody At 2.7 A Resolution Length = 326 | Back alignment and structure |
| >pdb|4DKL|A Chain A, Crystal Structure Of The Mu-Opioid Receptor Bound To A Morphinan Antagonist Length = 464 | Back alignment and structure |
| >pdb|4EIY|A Chain A, Crystal Structure Of The Chimeric Protein Of A2aar-Bril In Complex With Zm241385 At 1.8a Resolution Length = 447 | Back alignment and structure |
| >pdb|4EIY|A Chain A, Crystal Structure Of The Chimeric Protein Of A2aar-Bril In Complex With Zm241385 At 1.8a Resolution Length = 447 | Back alignment and structure |
| >pdb|2YDO|A Chain A, Thermostabilised Human A2a Receptor With Adenosine Bound Length = 325 | Back alignment and structure |
| >pdb|2YDO|A Chain A, Thermostabilised Human A2a Receptor With Adenosine Bound Length = 325 | Back alignment and structure |
| >pdb|3PWH|A Chain A, Thermostabilised Adenosine A2a Receptor Length = 329 | Back alignment and structure |
| >pdb|3PWH|A Chain A, Thermostabilised Adenosine A2a Receptor Length = 329 | Back alignment and structure |
| >pdb|4DJH|A Chain A, Structure Of The Human Kappa Opioid Receptor In Complex With Jdtic Length = 480 | Back alignment and structure |
| >pdb|4DJH|A Chain A, Structure Of The Human Kappa Opioid Receptor In Complex With Jdtic Length = 480 | Back alignment and structure |
| >pdb|4GBR|A Chain A, N-terminal T4 Lysozyme Fusion Facilitates Crystallization Of A G Protein Coupled Receptor Length = 309 | Back alignment and structure |
| >pdb|3UON|A Chain A, Structure Of The Human M2 Muscarinic Acetylcholine Receptor Bound To An Antagonist Length = 467 | Back alignment and structure |
| >pdb|3UON|A Chain A, Structure Of The Human M2 Muscarinic Acetylcholine Receptor Bound To An Antagonist Length = 467 | Back alignment and structure |
| >pdb|4EJ4|A Chain A, Structure Of The Delta Opioid Receptor Bound To Naltrindole Length = 461 | Back alignment and structure |
| >pdb|2VT4|A Chain A, Turkey Beta1 Adrenergic Receptor With Stabilising Mutations And Bound Cyanopindolol Length = 313 | Back alignment and structure |
| >pdb|2Y00|B Chain B, Turkey Beta1 Adrenergic Receptor With Stabilising Mutations And Bound Partial Agonist Dobutamine (Crystal Dob92) Length = 315 | Back alignment and structure |
| >pdb|2KS9|A Chain A, Solution Conformation Of Substance P In Water Complexed With Nk1r Length = 364 | Back alignment and structure |
| >pdb|3VW7|A Chain A, Crystal Structure Of Human Protease-Activated Receptor 1 (Par1) Bound With Antagonist Vorapaxar At 2.2 Angstrom Length = 484 | Back alignment and structure |
| >pdb|3SN6|R Chain R, Crystal Structure Of The Beta2 Adrenergic Receptor-Gs Protein Complex Length = 514 | Back alignment and structure |
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 419 | |||
| 4ea3_A | 434 | Fusion protein of nociceptin receptor and cytochr; | 2e-37 | |
| 4ea3_A | 434 | Fusion protein of nociceptin receptor and cytochr; | 3e-18 | |
| 2ks9_A | 364 | Substance-P receptor; water, autodock, NK1, neurop | 4e-37 | |
| 4dkl_A | 464 | MU-type opioid receptor, lysozyme chimera; G-prote | 2e-24 | |
| 4dkl_A | 464 | MU-type opioid receptor, lysozyme chimera; G-prote | 1e-16 | |
| 4dkl_A | 464 | MU-type opioid receptor, lysozyme chimera; G-prote | 6e-05 | |
| 4dkl_A | 464 | MU-type opioid receptor, lysozyme chimera; G-prote | 6e-04 | |
| 1u19_A | 349 | Rhodopsin; G protein-coupled receptor, membrane pr | 2e-23 | |
| 1u19_A | 349 | Rhodopsin; G protein-coupled receptor, membrane pr | 1e-11 | |
| 3odu_A | 502 | C-X-C chemokine receptor type 4, lysozyme chimera; | 4e-22 | |
| 3odu_A | 502 | C-X-C chemokine receptor type 4, lysozyme chimera; | 2e-16 | |
| 3odu_A | 502 | C-X-C chemokine receptor type 4, lysozyme chimera; | 2e-04 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 6e-19 | |
| 3eml_A | 488 | Human adenosine A2A receptor/T4 lysozyme chimera; | 2e-15 | |
| 3eml_A | 488 | Human adenosine A2A receptor/T4 lysozyme chimera; | 1e-14 | |
| 3v2y_A | 520 | Sphingosine 1-phosphate receptor 1, lysozyme CHIM; | 3e-15 | |
| 3v2y_A | 520 | Sphingosine 1-phosphate receptor 1, lysozyme CHIM; | 3e-11 | |
| 3uon_A | 467 | Human M2 muscarinic acetylcholine, receptor T4 LY | 4e-15 | |
| 3uon_A | 467 | Human M2 muscarinic acetylcholine, receptor T4 LY | 7e-13 | |
| 3sn6_R | 514 | Lysozyme, beta-2 adrenergic receptor; seven transm | 5e-15 | |
| 3rze_A | 452 | Histamine H1 receptor, lysozyme chimera; structura | 7e-15 | |
| 3rze_A | 452 | Histamine H1 receptor, lysozyme chimera; structura | 4e-12 | |
| 4eiy_A | 447 | Adenosine receptor A2A/soluble cytochrome B562 CH; | 4e-14 | |
| 4eiy_A | 447 | Adenosine receptor A2A/soluble cytochrome B562 CH; | 6e-14 | |
| 4amj_A | 315 | Beta-1 adrenergic receptor; membrane protein, 7TMR | 4e-14 | |
| 2rh1_A | 500 | Beta-2-adrenergic receptor/T4-lysozyme chimera; GP | 5e-13 | |
| 2rh1_A | 500 | Beta-2-adrenergic receptor/T4-lysozyme chimera; GP | 7e-13 | |
| 3pbl_A | 481 | D(3) dopamine receptor, lysozyme chimera; structur | 8e-13 | |
| 3pbl_A | 481 | D(3) dopamine receptor, lysozyme chimera; structur | 1e-11 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 1e-07 |
| >2ks9_A Substance-P receptor; water, autodock, NK1, neuropeptide receptor-NEU complex; NMR {Homo sapiens} PDB: 2ksa_A 2ksb_A Length = 364 | Back alignment and structure |
|---|
| >4dkl_A MU-type opioid receptor, lysozyme chimera; G-protein coupled receptor, 7 transmembrane receptor, signal protein-antagonist complex; HET: BF0 CLR MPG 1PE; 2.80A {Mus musculus} PDB: 4ej4_A* 4djh_A* Length = 464 | Back alignment and structure |
|---|
| >4dkl_A MU-type opioid receptor, lysozyme chimera; G-protein coupled receptor, 7 transmembrane receptor, signal protein-antagonist complex; HET: BF0 CLR MPG 1PE; 2.80A {Mus musculus} PDB: 4ej4_A* 4djh_A* Length = 464 | Back alignment and structure |
|---|
| >4dkl_A MU-type opioid receptor, lysozyme chimera; G-protein coupled receptor, 7 transmembrane receptor, signal protein-antagonist complex; HET: BF0 CLR MPG 1PE; 2.80A {Mus musculus} PDB: 4ej4_A* 4djh_A* Length = 464 | Back alignment and structure |
|---|
| >4dkl_A MU-type opioid receptor, lysozyme chimera; G-protein coupled receptor, 7 transmembrane receptor, signal protein-antagonist complex; HET: BF0 CLR MPG 1PE; 2.80A {Mus musculus} PDB: 4ej4_A* 4djh_A* Length = 464 | Back alignment and structure |
|---|
| >1u19_A Rhodopsin; G protein-coupled receptor, membrane protein, retinal protei photoreceptor, signaling protein; HET: MAN NAG BMA RET PLM HTO HTG; 2.20A {Bos taurus} SCOP: f.13.1.2 PDB: 1hzx_A* 1gzm_A* 1l9h_A* 2g87_A* 2hpy_A* 2i35_A* 2i36_A* 2i37_A* 2ped_A* 3oax_A* 3c9l_A* 1jfp_A* 1ln6_A* 1f88_A* 3cap_A* 3dqb_A* 3pqr_A* 3pxo_A* 3c9m_A* 2x72_A* ... Length = 349 | Back alignment and structure |
|---|
| >1u19_A Rhodopsin; G protein-coupled receptor, membrane protein, retinal protei photoreceptor, signaling protein; HET: MAN NAG BMA RET PLM HTO HTG; 2.20A {Bos taurus} SCOP: f.13.1.2 PDB: 1hzx_A* 1gzm_A* 1l9h_A* 2g87_A* 2hpy_A* 2i35_A* 2i36_A* 2i37_A* 2ped_A* 3oax_A* 3c9l_A* 1jfp_A* 1ln6_A* 1f88_A* 3cap_A* 3dqb_A* 3pqr_A* 3pxo_A* 3c9m_A* 2x72_A* ... Length = 349 | Back alignment and structure |
|---|
| >3odu_A C-X-C chemokine receptor type 4, lysozyme chimera; structural genomics, PSI-2, protein structure initiative; HET: ITD OLC OLA; 2.50A {Homo sapiens} PDB: 3oe8_A* 3oe6_A* 3oe0_A* 3oe9_A* 2k03_B* 2k04_B 2k05_B* Length = 502 | Back alignment and structure |
|---|
| >3odu_A C-X-C chemokine receptor type 4, lysozyme chimera; structural genomics, PSI-2, protein structure initiative; HET: ITD OLC OLA; 2.50A {Homo sapiens} PDB: 3oe8_A* 3oe6_A* 3oe0_A* 3oe9_A* 2k03_B* 2k04_B 2k05_B* Length = 502 | Back alignment and structure |
|---|
| >3odu_A C-X-C chemokine receptor type 4, lysozyme chimera; structural genomics, PSI-2, protein structure initiative; HET: ITD OLC OLA; 2.50A {Homo sapiens} PDB: 3oe8_A* 3oe6_A* 3oe0_A* 3oe9_A* 2k03_B* 2k04_B 2k05_B* Length = 502 | Back alignment and structure |
|---|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
| >3eml_A Human adenosine A2A receptor/T4 lysozyme chimera; caffeine, GPCR, membrane protein, LCP, mesophase, structural genomics, PSI-2; HET: ZMA STE; 2.60A {Homo sapiens} PDB: 3qak_A* Length = 488 | Back alignment and structure |
|---|
| >3eml_A Human adenosine A2A receptor/T4 lysozyme chimera; caffeine, GPCR, membrane protein, LCP, mesophase, structural genomics, PSI-2; HET: ZMA STE; 2.60A {Homo sapiens} PDB: 3qak_A* Length = 488 | Back alignment and structure |
|---|
| >3v2y_A Sphingosine 1-phosphate receptor 1, lysozyme CHIM; EDG receptor, lipid receptor, multiple sclerosi autoimmunity, structural genomics, PSI-biology; HET: ML5 NAG; 2.80A {Homo sapiens} PDB: 3v2w_A* Length = 520 | Back alignment and structure |
|---|
| >3v2y_A Sphingosine 1-phosphate receptor 1, lysozyme CHIM; EDG receptor, lipid receptor, multiple sclerosi autoimmunity, structural genomics, PSI-biology; HET: ML5 NAG; 2.80A {Homo sapiens} PDB: 3v2w_A* Length = 520 | Back alignment and structure |
|---|
| >3uon_A Human M2 muscarinic acetylcholine, receptor T4 LY fusion protein; G protein-coupled receptor, GPCR, SI protein-antagonist complex; HET: QNB BGC; 3.00A {Homo sapiens} PDB: 4daj_A* Length = 467 | Back alignment and structure |
|---|
| >3uon_A Human M2 muscarinic acetylcholine, receptor T4 LY fusion protein; G protein-coupled receptor, GPCR, SI protein-antagonist complex; HET: QNB BGC; 3.00A {Homo sapiens} PDB: 4daj_A* Length = 467 | Back alignment and structure |
|---|
| >3sn6_R Lysozyme, beta-2 adrenergic receptor; seven transmembrane receptor, nanobody, G protein-coupled RE GPCR, signal transduction, G protein signaling; HET: P0G; 3.20A {Enterobacteria phage T4} PDB: 3kj6_A 2r4s_A 2r4r_A Length = 514 | Back alignment and structure |
|---|
| >3rze_A Histamine H1 receptor, lysozyme chimera; structural genomics, PSI-biology, membrane protein, GPCR NET GPCR, hydrolase; HET: 5EH D7V OLC; 3.10A {Homo sapiens} Length = 452 | Back alignment and structure |
|---|
| >3rze_A Histamine H1 receptor, lysozyme chimera; structural genomics, PSI-biology, membrane protein, GPCR NET GPCR, hydrolase; HET: 5EH D7V OLC; 3.10A {Homo sapiens} Length = 452 | Back alignment and structure |
|---|
| >4eiy_A Adenosine receptor A2A/soluble cytochrome B562 CH; novel protein engineering, GPCR network, PSI-biology, struct genomics, membrane protein, GPCR; HET: ZMA CLR OLA OLC OLB; 1.80A {Homo sapiens} PDB: 3vg9_A* 3vga_A* 2ydv_A* 2ydo_A* 3uza_A* 3rey_A* 3rfm_A* 3pwh_A* 3uzc_A* 4er9_A Length = 447 | Back alignment and structure |
|---|
| >4eiy_A Adenosine receptor A2A/soluble cytochrome B562 CH; novel protein engineering, GPCR network, PSI-biology, struct genomics, membrane protein, GPCR; HET: ZMA CLR OLA OLC OLB; 1.80A {Homo sapiens} PDB: 3vg9_A* 3vga_A* 2ydv_A* 2ydo_A* 3uza_A* 3rey_A* 3rfm_A* 3pwh_A* 3uzc_A* 4er9_A Length = 447 | Back alignment and structure |
|---|
| >4amj_A Beta-1 adrenergic receptor; membrane protein, 7TMR BETA1-adrenoceptor, stabilising mutat biased agonist; HET: CVD 2CV; 2.30A {Meleagris gallopavo} PDB: 2y01_A* 2y02_A* 2y03_A* 2y04_A* 4ami_A* 2y00_A* 2vt4_A* 2ycw_A* 2ycx_A* 2ycy_A* 2ycz_A* Length = 315 | Back alignment and structure |
|---|
| >2rh1_A Beta-2-adrenergic receptor/T4-lysozyme chimera; GPCR, 7TM, fusion, lipidic cubic phase, lipidic, mesophase, cholesterol, membrane protein; HET: MAL CAU CLR PLM 12P; 2.40A {Homo sapiens} PDB: 3p0g_A* 3d4s_A* 3ny8_A* 3ny9_A* 3nya_A* 3pds_A* Length = 500 | Back alignment and structure |
|---|
| >2rh1_A Beta-2-adrenergic receptor/T4-lysozyme chimera; GPCR, 7TM, fusion, lipidic cubic phase, lipidic, mesophase, cholesterol, membrane protein; HET: MAL CAU CLR PLM 12P; 2.40A {Homo sapiens} PDB: 3p0g_A* 3d4s_A* 3ny8_A* 3ny9_A* 3nya_A* 3pds_A* Length = 500 | Back alignment and structure |
|---|
| >3pbl_A D(3) dopamine receptor, lysozyme chimera; structural genomics, PSI-2, protein structure initiative, AC technologies center for gene to 3D structure; HET: ETQ MAL; 2.89A {Homo sapiens} Length = 481 | Back alignment and structure |
|---|
| >3pbl_A D(3) dopamine receptor, lysozyme chimera; structural genomics, PSI-2, protein structure initiative, AC technologies center for gene to 3D structure; HET: ETQ MAL; 2.89A {Homo sapiens} Length = 481 | Back alignment and structure |
|---|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 419 | |||
| 4grv_A | 510 | Neurotensin receptor type 1, lysozyme chimera; G-p | 100.0 | |
| 2ks9_A | 364 | Substance-P receptor; water, autodock, NK1, neurop | 100.0 | |
| 3odu_A | 502 | C-X-C chemokine receptor type 4, lysozyme chimera; | 100.0 | |
| 2lnl_A | 296 | C-X-C chemokine receptor type 1; G protein coupled | 100.0 | |
| 3vw7_A | 484 | Proteinase-activated receptor 1, lysozyme; high re | 100.0 | |
| 4dkl_A | 464 | MU-type opioid receptor, lysozyme chimera; G-prote | 100.0 | |
| 1u19_A | 349 | Rhodopsin; G protein-coupled receptor, membrane pr | 100.0 | |
| 2rh1_A | 500 | Beta-2-adrenergic receptor/T4-lysozyme chimera; GP | 100.0 | |
| 3uon_A | 467 | Human M2 muscarinic acetylcholine, receptor T4 LY | 100.0 | |
| 4ea3_A | 434 | Fusion protein of nociceptin receptor and cytochr; | 100.0 | |
| 3v2y_A | 520 | Sphingosine 1-phosphate receptor 1, lysozyme CHIM; | 99.98 | |
| 3pbl_A | 481 | D(3) dopamine receptor, lysozyme chimera; structur | 99.97 | |
| 3rze_A | 452 | Histamine H1 receptor, lysozyme chimera; structura | 99.97 | |
| 3eml_A | 488 | Human adenosine A2A receptor/T4 lysozyme chimera; | 99.97 | |
| 4amj_A | 315 | Beta-1 adrenergic receptor; membrane protein, 7TMR | 99.97 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 99.97 | |
| 4eiy_A | 447 | Adenosine receptor A2A/soluble cytochrome B562 CH; | 99.97 | |
| 3sn6_R | 514 | Lysozyme, beta-2 adrenergic receptor; seven transm | 99.96 | |
| 2lnl_A | 296 | C-X-C chemokine receptor type 1; G protein coupled | 99.64 | |
| 4grv_A | 510 | Neurotensin receptor type 1, lysozyme chimera; G-p | 99.5 | |
| 3rze_A | 452 | Histamine H1 receptor, lysozyme chimera; structura | 99.48 | |
| 3v2y_A | 520 | Sphingosine 1-phosphate receptor 1, lysozyme CHIM; | 99.46 | |
| 3odu_A | 502 | C-X-C chemokine receptor type 4, lysozyme chimera; | 99.45 | |
| 3uon_A | 467 | Human M2 muscarinic acetylcholine, receptor T4 LY | 99.44 | |
| 4dkl_A | 464 | MU-type opioid receptor, lysozyme chimera; G-prote | 99.44 | |
| 3eml_A | 488 | Human adenosine A2A receptor/T4 lysozyme chimera; | 99.44 | |
| 3vw7_A | 484 | Proteinase-activated receptor 1, lysozyme; high re | 99.44 | |
| 3pbl_A | 481 | D(3) dopamine receptor, lysozyme chimera; structur | 99.42 | |
| 2ks9_A | 364 | Substance-P receptor; water, autodock, NK1, neurop | 99.41 | |
| 4ea3_A | 434 | Fusion protein of nociceptin receptor and cytochr; | 99.41 | |
| 2rh1_A | 500 | Beta-2-adrenergic receptor/T4-lysozyme chimera; GP | 99.39 | |
| 1u19_A | 349 | Rhodopsin; G protein-coupled receptor, membrane pr | 99.37 | |
| 4eiy_A | 447 | Adenosine receptor A2A/soluble cytochrome B562 CH; | 99.34 | |
| 3sn6_R | 514 | Lysozyme, beta-2 adrenergic receptor; seven transm | 99.32 | |
| 2z73_A | 448 | Rhodopsin; visual pigment, GQ-type, G-protein coup | 99.31 | |
| 4amj_A | 315 | Beta-1 adrenergic receptor; membrane protein, 7TMR | 99.25 | |
| 1hll_A | 32 | Alpha-2A adrenergic receptor; helix-linker-helix, | 98.14 | |
| 2koe_A | 40 | Human cannabinoid receptor 1 - helix 7/8 peptide; | 97.72 | |
| 1hll_A | 32 | Alpha-2A adrenergic receptor; helix-linker-helix, | 97.53 | |
| 2lot_A | 64 | Apelin receptor; membrane protein; NMR {Homo sapie | 92.66 | |
| 2lot_A | 64 | Apelin receptor; membrane protein; NMR {Homo sapie | 90.25 | |
| 2ki9_A | 33 | Cannabinoid receptor 2; GPCR, G-protein coupled re | 83.22 |
| >4grv_A Neurotensin receptor type 1, lysozyme chimera; G-protein coupled receptor, G-protein, signaling protein-agonist complex; HET: EPE; 2.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=316.67 Aligned_cols=193 Identities=23% Similarity=0.364 Sum_probs=155.2
Q ss_pred cchHHHHHHHHHHHHHHhhhheeeEEeEeccc---ccchhhHHHHHHHHHHHHHHHHhhHHHHHHhhcccccccccceee
Q psy17031 93 LNTEQFVILWALFILIVLGNSAVIFTLKFGVK---RRSRMNFFIMHLAVADLCVGVLSVLTDIVWRSSVTWKAGNTACKV 169 (419)
Q Consensus 93 ~~~~~~~~~~~i~~vgl~gN~lvl~~i~~~~~---~~~~~~~~i~~La~aDll~~~~~~p~~~~~~~~~~~~~~~~~C~~ 169 (419)
.+....+++.+++++|++||+++++++.++++ +++++|+|+.|||++|++++++.+|..++.....
T Consensus 31 ~~v~~~~~~~~i~~~g~~gN~lvi~~i~~~~~~r~~~~~~n~~i~~La~aDll~~~~~~p~~~~~~~~~----------- 99 (510)
T 4grv_A 31 SKVLVTAIYLALFVVGTVGNSVTLFTLARKKSLQSLQSTVHYHLGSLALSDLLILLLAMPVELYNFIWV----------- 99 (510)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHTSCC----CCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTTC-----------
T ss_pred HHHHHHHHHHHHHHHHHHHHHHhhhheeeecCCCCCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh-----------
Confidence 35566778889999999999999988877654 4588999999999999999999999888754321
Q ss_pred eeeeceeehhhhhhHHHHHhhhhhhhhccCcccccccchhcccccceeeeeeeeeeecceeccccccccchhhhHHHHHH
Q psy17031 170 VRYSQAVVTYSSTYVLVALSIDRYYAIKYPMNFCGSCKYIRDLCVGVLSVLTDIVWRSSVTWKAGNTACKVVRYSQAVVT 249 (419)
Q Consensus 170 ~~~~~~~~~~~s~~~L~~is~dRy~aI~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~~~~~C~~~~~~~~~~~ 249 (419)
...|.+|+..|++..++...+.
T Consensus 100 ----------------------------------------------------------~~~w~~g~~~C~~~~~~~~~~~ 121 (510)
T 4grv_A 100 ----------------------------------------------------------HHPWAFGDAGCRGYYFLRDACT 121 (510)
T ss_dssp ----------------------------------------------------------CSSCSSHHHHHHHHHHHHHHHH
T ss_pred ----------------------------------------------------------CCCEEhhHHHHHHHHHHHHHHH
Confidence 1234566677888888888889
Q ss_pred HHHHHHHHHHHHhhheeeeccccccc--cchhhhHHHHHHHHHHHHHHHHHHHhheeEeecCC------Cceeeccccch
Q psy17031 250 YSSTYVLVALSIDRYYAIKYPMNFCG--SWRRARWLVGIAWLISFILSIPIAVLFHVRLVQGT------SQCWIEFEKPW 321 (419)
Q Consensus 250 ~~s~~~l~~i~~~Ry~~i~~p~~~~~--t~~~~~~~i~~~W~~s~~~~~p~~~~~~~~~~~~~------~~C~~~~~~~~ 321 (419)
.+|.+.+++|++|||.+|++|++|+. +++++..+++++|++++++++|+++..+....... ..|...++. .
T Consensus 122 ~~S~~~l~~is~dRy~ai~~P~~~~~~~t~~~~~~~i~~~W~~s~~~~~p~~~~~~~~~~~~~~~~~~~~~c~~~~~~-~ 200 (510)
T 4grv_A 122 YATALNVASLSVARYLAICHPFKAKTLMSRSRTKKFISAIWLASALLAIPMLFTMGLQNRSADGTHPGGLVCTPIVDT-A 200 (510)
T ss_dssp HHHHHHHHHHHHHHHHHHHSCCCCCCCCCCSCCHHHHHHHHHHHHHHHTTHHHHEEEEECSSSSCCGGGEEEEECSCH-H
T ss_pred HHHHHHHHHHHHHheEEEeccccccccccccccceeehHHHHHHHHHHHHHHHhhcccccccCCCCCCcccccccccc-c
Confidence 99999999999999999999999987 88999999999999999999999988766544321 235544433 3
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q psy17031 322 QWQLYMSLVALALFVIPAVIISICYILIITTIWA 355 (419)
Q Consensus 322 ~~~~~~~~~~~~~~~vp~~ii~~~y~~i~~~l~~ 355 (419)
....+..+..++.|++|+++|+++|.+|++++|+
T Consensus 201 ~~~~~~~~~~~~~f~iP~~ii~~~Y~~I~~~l~~ 234 (510)
T 4grv_A 201 TVKVVIQVNTFMSFLFPMLVISILNTVIANKLTV 234 (510)
T ss_dssp HHHHHHHHHHHHHTHHHHHHHHHHHHHHHHHHHT
T ss_pred hhhhhhhhhhhHHHhhhHHHHHHHHHHHHHHHHH
Confidence 4456666677888999999999999999998874
|
| >2ks9_A Substance-P receptor; water, autodock, NK1, neuropeptide receptor-NEU complex; NMR {Homo sapiens} PDB: 2ksa_A 2ksb_A | Back alignment and structure |
|---|
| >3odu_A C-X-C chemokine receptor type 4, lysozyme chimera; structural genomics, PSI-2, protein structure initiative; HET: ITD OLC OLA; 2.50A {Homo sapiens} PDB: 3oe8_A* 3oe6_A* 3oe0_A* 3oe9_A* 2k03_B* 2k04_B 2k05_B* | Back alignment and structure |
|---|
| >2lnl_A C-X-C chemokine receptor type 1; G protein coupled receptor, GPCR, membrane protei transmembrane, 7TM, phospholipid, signaling, signaling PROT; NMR {Homo sapiens} | Back alignment and structure |
|---|
| >3vw7_A Proteinase-activated receptor 1, lysozyme; high resolution structure, protease-activated receptor 1, in conformation, antagonist vorapaxar; HET: VPX OLC; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
| >4dkl_A MU-type opioid receptor, lysozyme chimera; G-protein coupled receptor, 7 transmembrane receptor, signal protein-antagonist complex; HET: BF0 CLR MPG 1PE; 2.80A {Mus musculus} PDB: 4ej4_A* 4djh_A* | Back alignment and structure |
|---|
| >1u19_A Rhodopsin; G protein-coupled receptor, membrane protein, retinal protei photoreceptor, signaling protein; HET: MAN NAG BMA RET PLM HTO HTG; 2.20A {Bos taurus} SCOP: f.13.1.2 PDB: 1hzx_A* 1gzm_A* 1l9h_A* 2g87_A* 2hpy_A* 2i35_A* 2i36_A* 2i37_A* 2ped_A* 3oax_A* 3c9l_A* 1jfp_A* 1ln6_A* 1f88_A* 3cap_A* 3dqb_A* 3pqr_A* 3pxo_A* 3c9m_A* 2x72_A* ... | Back alignment and structure |
|---|
| >2rh1_A Beta-2-adrenergic receptor/T4-lysozyme chimera; GPCR, 7TM, fusion, lipidic cubic phase, lipidic, mesophase, cholesterol, membrane protein; HET: MAL CAU CLR PLM 12P; 2.40A {Homo sapiens} PDB: 3p0g_A* 3d4s_A* 3ny8_A* 3ny9_A* 3nya_A* 3pds_A* | Back alignment and structure |
|---|
| >3uon_A Human M2 muscarinic acetylcholine, receptor T4 LY fusion protein; G protein-coupled receptor, GPCR, SI protein-antagonist complex; HET: QNB BGC; 3.00A {Homo sapiens} PDB: 4daj_A* | Back alignment and structure |
|---|
| >3v2y_A Sphingosine 1-phosphate receptor 1, lysozyme CHIM; EDG receptor, lipid receptor, multiple sclerosi autoimmunity, structural genomics, PSI-biology; HET: ML5 NAG; 2.80A {Homo sapiens} PDB: 3v2w_A* | Back alignment and structure |
|---|
| >3pbl_A D(3) dopamine receptor, lysozyme chimera; structural genomics, PSI-2, PSI-biology, protein structure initiative; HET: ETQ MAL; 2.89A {Homo sapiens} | Back alignment and structure |
|---|
| >3rze_A Histamine H1 receptor, lysozyme chimera; structural genomics, PSI-biology, membrane protein, GPCR NET GPCR, hydrolase; HET: 5EH D7V OLC; 3.10A {Homo sapiens} | Back alignment and structure |
|---|
| >3eml_A Human adenosine A2A receptor/T4 lysozyme chimera; caffeine, GPCR, membrane protein, LCP, mesophase, structural genomics, PSI-2; HET: ZMA STE; 2.60A {Homo sapiens} PDB: 3qak_A* | Back alignment and structure |
|---|
| >4amj_A Beta-1 adrenergic receptor; membrane protein, 7TMR BETA1-adrenoceptor, stabilising mutat biased agonist; HET: CVD 2CV; 2.30A {Meleagris gallopavo} PDB: 2y01_A* 2y02_A* 2y03_A* 2y04_A* 4ami_A* 2y00_A* 2vt4_A* 2ycw_A* 2ycx_A* 2ycy_A* 2ycz_A* | Back alignment and structure |
|---|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* | Back alignment and structure |
|---|
| >4eiy_A Adenosine receptor A2A/soluble cytochrome B562 CH; novel protein engineering, GPCR network, PSI-biology, struct genomics, membrane protein, GPCR; HET: ZMA CLR OLA OLC OLB; 1.80A {Homo sapiens} PDB: 3vg9_A* 3vga_A* 2ydv_A* 2ydo_A* 3uza_A* 3rey_A* 3rfm_A* 3pwh_A* 3uzc_A* 4er9_A | Back alignment and structure |
|---|
| >3sn6_R Lysozyme, beta-2 adrenergic receptor; seven transmembrane receptor, nanobody, G protein-coupled RE GPCR, signal transduction, G protein signaling; HET: P0G; 3.20A {Enterobacteria phage T4} PDB: 3kj6_A 2r4s_A 2r4r_A 4gbr_A* | Back alignment and structure |
|---|
| >2lnl_A C-X-C chemokine receptor type 1; G protein coupled receptor, GPCR, membrane protei transmembrane, 7TM, phospholipid, signaling, signaling PROT; NMR {Homo sapiens} | Back alignment and structure |
|---|
| >4grv_A Neurotensin receptor type 1, lysozyme chimera; G-protein coupled receptor, G-protein, signaling protein-agonist complex; HET: EPE; 2.80A {Rattus norvegicus} | Back alignment and structure |
|---|
| >3rze_A Histamine H1 receptor, lysozyme chimera; structural genomics, PSI-biology, membrane protein, GPCR NET GPCR, hydrolase; HET: 5EH D7V OLC; 3.10A {Homo sapiens} | Back alignment and structure |
|---|
| >3v2y_A Sphingosine 1-phosphate receptor 1, lysozyme CHIM; EDG receptor, lipid receptor, multiple sclerosi autoimmunity, structural genomics, PSI-biology; HET: ML5 NAG; 2.80A {Homo sapiens} PDB: 3v2w_A* | Back alignment and structure |
|---|
| >3odu_A C-X-C chemokine receptor type 4, lysozyme chimera; structural genomics, PSI-2, protein structure initiative; HET: ITD OLC OLA; 2.50A {Homo sapiens} PDB: 3oe8_A* 3oe6_A* 3oe0_A* 3oe9_A* 2k03_B* 2k04_B 2k05_B* | Back alignment and structure |
|---|
| >3uon_A Human M2 muscarinic acetylcholine, receptor T4 LY fusion protein; G protein-coupled receptor, GPCR, SI protein-antagonist complex; HET: QNB BGC; 3.00A {Homo sapiens} PDB: 4daj_A* | Back alignment and structure |
|---|
| >4dkl_A MU-type opioid receptor, lysozyme chimera; G-protein coupled receptor, 7 transmembrane receptor, signal protein-antagonist complex; HET: BF0 CLR MPG 1PE; 2.80A {Mus musculus} PDB: 4ej4_A* 4djh_A* | Back alignment and structure |
|---|
| >3eml_A Human adenosine A2A receptor/T4 lysozyme chimera; caffeine, GPCR, membrane protein, LCP, mesophase, structural genomics, PSI-2; HET: ZMA STE; 2.60A {Homo sapiens} PDB: 3qak_A* | Back alignment and structure |
|---|
| >3vw7_A Proteinase-activated receptor 1, lysozyme; high resolution structure, protease-activated receptor 1, in conformation, antagonist vorapaxar; HET: VPX OLC; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
| >3pbl_A D(3) dopamine receptor, lysozyme chimera; structural genomics, PSI-2, PSI-biology, protein structure initiative; HET: ETQ MAL; 2.89A {Homo sapiens} | Back alignment and structure |
|---|
| >2ks9_A Substance-P receptor; water, autodock, NK1, neuropeptide receptor-NEU complex; NMR {Homo sapiens} PDB: 2ksa_A 2ksb_A | Back alignment and structure |
|---|
| >2rh1_A Beta-2-adrenergic receptor/T4-lysozyme chimera; GPCR, 7TM, fusion, lipidic cubic phase, lipidic, mesophase, cholesterol, membrane protein; HET: MAL CAU CLR PLM 12P; 2.40A {Homo sapiens} PDB: 3p0g_A* 3d4s_A* 3ny8_A* 3ny9_A* 3nya_A* 3pds_A* | Back alignment and structure |
|---|
| >1u19_A Rhodopsin; G protein-coupled receptor, membrane protein, retinal protei photoreceptor, signaling protein; HET: MAN NAG BMA RET PLM HTO HTG; 2.20A {Bos taurus} SCOP: f.13.1.2 PDB: 1hzx_A* 1gzm_A* 1l9h_A* 2g87_A* 2hpy_A* 2i35_A* 2i36_A* 2i37_A* 2ped_A* 3oax_A* 3c9l_A* 1jfp_A* 1ln6_A* 1f88_A* 3cap_A* 3dqb_A* 3pqr_A* 3pxo_A* 3c9m_A* 2x72_A* ... | Back alignment and structure |
|---|
| >4eiy_A Adenosine receptor A2A/soluble cytochrome B562 CH; novel protein engineering, GPCR network, PSI-biology, struct genomics, membrane protein, GPCR; HET: ZMA CLR OLA OLC OLB; 1.80A {Homo sapiens} PDB: 3vg9_A* 3vga_A* 2ydv_A* 2ydo_A* 3uza_A* 3rey_A* 3rfm_A* 3pwh_A* 3uzc_A* 4er9_A | Back alignment and structure |
|---|
| >3sn6_R Lysozyme, beta-2 adrenergic receptor; seven transmembrane receptor, nanobody, G protein-coupled RE GPCR, signal transduction, G protein signaling; HET: P0G; 3.20A {Enterobacteria phage T4} PDB: 3kj6_A 2r4s_A 2r4r_A 4gbr_A* | Back alignment and structure |
|---|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* | Back alignment and structure |
|---|
| >4amj_A Beta-1 adrenergic receptor; membrane protein, 7TMR BETA1-adrenoceptor, stabilising mutat biased agonist; HET: CVD 2CV; 2.30A {Meleagris gallopavo} PDB: 2y01_A* 2y02_A* 2y03_A* 2y04_A* 4ami_A* 2y00_A* 2vt4_A* 2ycw_A* 2ycx_A* 2ycy_A* 2ycz_A* | Back alignment and structure |
|---|
| >1hll_A Alpha-2A adrenergic receptor; helix-linker-helix, membrane protein; NMR {Synthetic} SCOP: j.94.1.1 PDB: 1hof_A 1ho9_A 1hod_A | Back alignment and structure |
|---|
| >2koe_A Human cannabinoid receptor 1 - helix 7/8 peptide; GPCR, HCB1, membrane protein, signaling protein; NMR {Homo sapiens} | Back alignment and structure |
|---|
| >1hll_A Alpha-2A adrenergic receptor; helix-linker-helix, membrane protein; NMR {Synthetic} SCOP: j.94.1.1 PDB: 1hof_A 1ho9_A 1hod_A | Back alignment and structure |
|---|
| >2lot_A Apelin receptor; membrane protein; NMR {Homo sapiens} PDB: 2lou_A 2lov_A 2low_A | Back alignment and structure |
|---|
| >2lot_A Apelin receptor; membrane protein; NMR {Homo sapiens} PDB: 2lou_A 2lov_A 2low_A | Back alignment and structure |
|---|
| >2ki9_A Cannabinoid receptor 2; GPCR, G-protein coupled receptor, membrane protein; NMR {Synthetic} | Back alignment and structure |
|---|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 419 | ||||
| d1u19a_ | 348 | f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: | 8e-14 | |
| d1u19a_ | 348 | f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: | 5e-04 |
| >d1u19a_ f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} Length = 348 | Back information, alignment and structure |
|---|
class: Membrane and cell surface proteins and peptides fold: Family A G protein-coupled receptor-like superfamily: Family A G protein-coupled receptor-like family: Rhodopsin-like domain: Rhodopsin species: Cow (Bos taurus) [TaxId: 9913]
Score = 70.0 bits (170), Expect = 8e-14
Identities = 43/315 (13%), Positives = 92/315 (29%), Gaps = 46/315 (14%)
Query: 98 FVILWALFILIVLGNSAVIFTLKFGVKRRSRMNFFIMHLAVADLCVGVLSVLTDIVWRSS 157
++ L +L N ++ K R+ +N+ +++LAVADL + T +
Sbjct: 41 AAYMFLLIMLGFPINFLTLYVTVQHKKLRTPLNYILLNLAVADLFMVFGGFTTTLYTSLH 100
Query: 158 VTWKAGNTACKVVRYSQAVVTYSSTYVLVALSIDRYYAIKYPMNFCGSCKYIRDLCVGVL 217
+ G T C + + + + + LV L+I+RY + PM+ + + V
Sbjct: 101 GYFVFGPTGCNLEGFFATLGGEIALWSLVVLAIERYVVVCKPMSNFRFGENHAIMGV--- 157
Query: 218 SVLTDIVWRSSVTWKAGNTACKVVRYSQAVVTYSSTYVLVALSIDRYYAIKYPMNFCGSW 277
+ A + +
Sbjct: 158 --------------------AFTWVMALACAAPPLVGWSRYIPEGMQCSCGIDYYTPHEE 197
Query: 278 RRARWLVGIAWLISFILSIPIAVLFHVRLVQGTSQCWIEFEKPWQWQLYMSLVALALFVI 337
V +++ FI+ + + + +LV + + ++ Q V + ++
Sbjct: 198 TNNESFVIYMFVVHFIIPLIVIFFCYGQLVFTVKEAAAQQQESATTQKAEKEVTRMVIIM 257
Query: 338 PAVIISICYILIITTIWAKSKLYTFVLCWSPYIVFDLLQVYGYIPRTQNYIAVATLIQSL 397
F++CW PY
Sbjct: 258 VIA---------------------FLICWLPYAGVAFYIFTHQGSDFGPIFMTIPAF--F 294
Query: 398 APLNSAANPIIYCIF 412
A ++ NP+IY +
Sbjct: 295 AKTSAVYNPVIYIMM 309
|
| >d1u19a_ f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} Length = 348 | Back information, alignment and structure |
|---|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 419 | |||
| d1u19a_ | 348 | Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} | 99.97 | |
| d1u19a_ | 348 | Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} | 99.23 |
| >d1u19a_ f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Membrane and cell surface proteins and peptides fold: Family A G protein-coupled receptor-like superfamily: Family A G protein-coupled receptor-like family: Rhodopsin-like domain: Rhodopsin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.97 E-value=2.5e-31 Score=256.32 Aligned_cols=253 Identities=20% Similarity=0.291 Sum_probs=204.5
Q ss_pred chHHHHHHHHHHHHHHhhhheeeEEeEecccccchhhHHHHHHHHHHHHHHHHhhHHHHHHhhcccccccccceeeeeee
Q psy17031 94 NTEQFVILWALFILIVLGNSAVIFTLKFGVKRRSRMNFFIMHLAVADLCVGVLSVLTDIVWRSSVTWKAGNTACKVVRYS 173 (419)
Q Consensus 94 ~~~~~~~~~~i~~vgl~gN~lvl~~i~~~~~~~~~~~~~i~~La~aDll~~~~~~p~~~~~~~~~~~~~~~~~C~~~~~~ 173 (419)
.....+++.+++++|++||+++++++.++|++|++.|+++.|||++|++.++...|..+.....+.|
T Consensus 37 ~~~~~~~~~ii~v~gi~gN~lvi~vi~~~k~lr~~~~~~l~nLaiaDll~~~~~~~~~~~~~~~~~~------------- 103 (348)
T d1u19a_ 37 FSMLAAYMFLLIMLGFPINFLTLYVTVQHKKLRTPLNYILLNLAVADLFMVFGGFTTTLYTSLHGYF------------- 103 (348)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHSTTCCSHHHHHHHHHHHHHHHHHHHTHHHHHHHHHHTSC-------------
T ss_pred HHHHHHHHHHHHHHHHHHHHHeehhhhccCCCCCHhHHHHHHHHHHHHHHHHHHHHHhhhhhccCcc-------------
Confidence 4466677888999999999999999999999999999999999999999999999988776655444
Q ss_pred ceeehhhhhhHHHHHhhhhhhhhccCcccccccchhcccccceeeeeeeeeeecceeccccccccchhhhHHHHHHHHHH
Q psy17031 174 QAVVTYSSTYVLVALSIDRYYAIKYPMNFCGSCKYIRDLCVGVLSVLTDIVWRSSVTWKAGNTACKVVRYSQAVVTYSST 253 (419)
Q Consensus 174 ~~~~~~~s~~~L~~is~dRy~aI~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~~~~~C~~~~~~~~~~~~~s~ 253 (419)
..++..|+...+....+..++.
T Consensus 104 ----------------------------------------------------------~~~~~~c~~~~~~~~~~~~~s~ 125 (348)
T d1u19a_ 104 ----------------------------------------------------------VFGPTGCNLEGFFATLGGEIAL 125 (348)
T ss_dssp ----------------------------------------------------------TTHHHHHHHHHHHHHHHHHHHH
T ss_pred ----------------------------------------------------------ccCchhhhhhhhccccceeeec
Confidence 4455778888888888999999
Q ss_pred HHHHHHHHhhheeeeccccccc-cchhhhHHHHHHHHHHHHHHHHHHHhheeEee-cCCCceeeccc---cchhHHHHHH
Q psy17031 254 YVLVALSIDRYYAIKYPMNFCG-SWRRARWLVGIAWLISFILSIPIAVLFHVRLV-QGTSQCWIEFE---KPWQWQLYMS 328 (419)
Q Consensus 254 ~~l~~i~~~Ry~~i~~p~~~~~-t~~~~~~~i~~~W~~s~~~~~p~~~~~~~~~~-~~~~~C~~~~~---~~~~~~~~~~ 328 (419)
+.++++++|||.++++|++++. ++++....+..+|..++++..|+......... .+...|..... .......+..
T Consensus 126 ~~l~~is~~R~~~i~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (348)
T d1u19a_ 126 WSLVVLAIERYVVVCKPMSNFRFGENHAIMGVAFTWVMALACAAPPLVGWSRYIPEGMQCSCGIDYYTPHEETNNESFVI 205 (348)
T ss_dssp HHHHHHHHHHHHHHTCCSSSCCCCHHHHHHHHHHHHHHHHHHHSGGGTTSSCCEEETTTTEEECCCSCCCGGGTHHHHHH
T ss_pred chhhhhhcccceeeeccccccccccccccccceeeehhhhheecccccccceeccCCcccccccccccccccccchhhHH
Confidence 9999999999999999999887 77888888889999999988887776554433 33444543332 2233455666
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHhcCc----------------------eEEEEEechhHHHHHHHHHhcCcCCCch
Q psy17031 329 LVALALFVIPAVIISICYILIITTIWAKSK----------------------LYTFVLCWSPYIVFDLLQVYGYIPRTQN 386 (419)
Q Consensus 329 ~~~~~~~~vp~~ii~~~y~~i~~~l~~~~~----------------------~~~f~~cw~P~~v~~~~~~~~~~~~~~~ 386 (419)
....+.+++|++++.++|.++.+++||+++ +++|++||+|+.+..++.......+ .
T Consensus 206 ~~~~~~~~ip~~i~~~~y~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~f~~~~~P~~i~~~~~~~~~~~~--~ 283 (348)
T d1u19a_ 206 YMFVVHFIIPLIVIFFCYGQLVFTVKEAAAQQQESATTQKAEKEVTRMVIIMVIAFLICWLPYAGVAFYIFTHQGSD--F 283 (348)
T ss_dssp HHHHHTTHHHHHHHHHHHTTTTTSSCSCCCSSCSSSHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTTSC--C
T ss_pred HHHHHHHHHHHHHHHHHHHHHHhhhcccccccchhhhhHHHHhhHhheEEEeehHHHHHhhHHHhhhheeeccCCcc--c
Confidence 777888899999999999999999887654 6999999999999888766653322 2
Q ss_pred hhHHHHHHHHHhccccccchhhhhcccCCccCC
Q psy17031 387 YIAVATLIQSLAPLNSAANPIIYCIFRTGNNNR 419 (419)
Q Consensus 387 ~~~~~~~~~~l~~~~s~~nP~iY~~~~~~fR~~ 419 (419)
......+..+++.+|+++||+||.+++++|||+
T Consensus 284 ~~~~~~~~~~l~~~ns~iNPiIY~~~~~~fR~~ 316 (348)
T d1u19a_ 284 GPIFMTIPAFFAKTSAVYNPVIYIMMNKQFRNC 316 (348)
T ss_dssp CHHHHHHHHHHGGGGGTHHHHHHHHTCHHHHHH
T ss_pred cHHHHHHHHHHHHHHHHHHHHHHHhcCHHHHHH
Confidence 334566778899999999999999999999974
|
| >d1u19a_ f.13.1.2 (A:) Rhodopsin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|